Cullinan Therapeutics (NASDAQ:CGEM) Stock Rating Lowered by Wall Street Zen
Cullinan Therapeutics (NASDAQ:CGEM – Get Free Report) was downgraded by Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Sunday, Wall Street Zen reports. Several other analysts have also recently commented on CGEM. Weiss Ratings restated a “sell (d-)” rating on shares of Cullinan Therapeutics in a report […]
15 Sep 05:12 · The Markets Daily